Evotec (OTCMKTS:EVTCY) Shares Pass Below Fifty Day Moving Average - What's Next?

Key Points

• Evotec SE shares fell below their 50-day moving average of $4.08, trading as low as $3.75 during recent sessions.
• The company has a market capitalization of $1.24 billion and a P/E ratio of 9.15.
• Evotec operates primarily in drug discovery, offering fee-for-service solutions through its EVT Execute and EVT Innovate segments.

Evotec SE (OTCMKTS:EVTCY - Get Free Report)'s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $4.08 and traded as low as $3.75. Evotec shares last traded at $3.75, with a volume of 64,313 shares.

Evotec Stock Down 3.1%

The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The firm has a market cap of $1.26 billion, a PE ratio of 9.29 and a beta of 0.98. The business has a 50-day moving average price of $4.08 and a two-hundred day moving average price of $3.99.

About Evotec

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.